For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
5
views
51
references
 Top references
cited by
18
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      248
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sexual and gender minority (SGM) populations are particularly vulnerable to poor COVID-19 outcomes and are more likely to experience stigma and medical mistrust that may impact COVID-19 vaccine acceptance. This study examined the prevalence of COVID testing and diagnosis and assessed COVID-19 vaccine acceptance among a large sample of SGM. Participants were recruited as part of an online cross-sectional study focused on an HIV biomedical prevention technology willingness in the United States at increased risk for HIV sero-conversion. Multivariate linear analysis was conducted to examine COVID-19 vaccine acceptance. The study sample included 1350 predominately gay (61.6%), Black (57.9%), cis-gender (95.7%) males with a mean age of 32.9 years. Medical mistrust and social concern regarding COVID-19 vaccine stigma were significantly associated with decreased COVID-19 vaccine acceptance, and altruism was significantly associated with increased vaccine acceptance. Black participants were significantly less likely to accept a COVID-19 vaccine, and Asian participants were significantly more likely to accept a vaccine, compared to White peers. As the planning of COVID-19 vaccine rollout efforts is conceptualized and designed, these data may inform equitable implementation strategies and prevent worsening health inequities among SGM populations.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          A global survey of potential acceptance of a COVID-19 vaccine

          Jeffrey V Lazarus, Scott C Ratzan, Adam Palayew … (2020)
          Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.
          Article 0 comments Cited 1225 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Determinants of COVID-19 vaccine acceptance in the US

            Amyn A. Malik, SarahAnn McFadden, Jad Elharake … (2020)
            Background The COVID-19 pandemic continues to adversely affect the U.S., which leads globally in total cases and deaths. As COVID-19 vaccines are under development, public health officials and policymakers need to create strategic vaccine-acceptance messaging to effectively control the pandemic and prevent thousands of additional deaths. Methods Using an online platform, we surveyed the U.S. adult population in May 2020 to understand risk perceptions about the COVID-19 pandemic, acceptance of a COVID-19 vaccine, and trust in sources of information. These factors were compared across basic demographics. Findings Of the 672 participants surveyed, 450 (67%) said they would accept a COVID-19 vaccine if it is recommended for them. Males (72%) compared to females, older adults (≥55 years; 78%) compared to younger adults, Asians (81%) compared to other racial and ethnic groups, and college and/or graduate degree holders (75%) compared to people with less than a college degree were more likely to accept the vaccine. When comparing reported influenza vaccine uptake to reported acceptance of the COVID-19 vaccine: 1) participants who did not complete high school had a very low influenza vaccine uptake (10%), while 60% of the same group said they would accept the COVID-19 vaccine; 2) unemployed participants reported lower influenza uptake and lower COVID-19 vaccine acceptance when compared to those employed or retired; and, 3) Black Americans reported lower influenza vaccine uptake and lower COVID-19 vaccine acceptance than all other racial groups reported in our study. Lastly, we identified geographic differences with Department of Health and Human Services (DHHS) regions 2 (New York) and 5 (Chicago) reporting less than 50 percent COVID-19 vaccine acceptance. Interpretation Although our study found a 67% acceptance of a COVID-19 vaccine, there were noticeable demographic and geographical disparities in vaccine acceptance. Before a COVID-19 vaccine is introduced to the U.S., public health officials and policymakers must prioritize effective COVID-19 vaccine-acceptance messaging for all Americans, especially those who are most vulnerable.
            Article 0 comments Cited 622 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults

              Kimberly A Fisher, Sarah J. Bloomstone, Jeremy Walder … (2020)
              Once a vaccine for coronavirus disease 2019 becomes available, it will be important to maximize vaccine uptake and coverage. This national survey explores factors associated with vaccine hesitancy. The results suggest that multipronged efforts will be needed to increase acceptance of a coronavirus disease 2019 vaccine.
              Article 0 comments Cited 590 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                Alessandra Casuccio: Role: Academic Editor
                Journal
                Journal ID (nlm-ta): Vaccines (Basel)
                Journal ID (iso-abbrev): Vaccines (Basel)
                Journal ID (publisher-id): vaccines
                Title: Vaccines
                Publisher: MDPI
                ISSN (Electronic): 2076-393X
                Publication date (Electronic): 01 March 2021
                Publication date Collection: March 2021
                Volume: 9
                Issue: 3
                Electronic Location Identifier: 204
                Affiliations
                [1 ]Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; teixeird@ 123456pennmedicine.upenn.edu
                [2 ]Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia, PA 19104, USA; willey@ 123456nursing.upenn.edu
                [3 ]Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI 02912, USA; katie_biello@ 123456brown.edu (K.B.); pablo_valente@ 123456brown.edu (P.K.V.)
                [4 ]Fenway Health, Boston, MA 02215, USA; kmayer@ 123456fenwayhealth.org
                [5 ]Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA
                [6 ]Department of Medicine, School of Medicine, University of North Carolina—Chapel Hill, Chapel Hill, NC 27517, USA; lisa_hightow@ 123456med.unc.edu
                Author notes
                Author information
                https://orcid.org/0000-0003-3525-605X
                https://orcid.org/0000-0002-5017-5699
                https://orcid.org/0000-0002-2058-3472
                https://orcid.org/0000-0002-9276-2306
                Article
                Publisher ID: vaccines-09-00204
                DOI: 10.3390/vaccines9030204
                PMC ID: 7999863
                PubMed ID: 33804530
                SO-VID: 4a5e34e4-40d8-4d3a-9038-50227cba1c0e
                Copyright © © 2021 by the authors.
                License:

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                Date received : 05 February 2021
                Date accepted : 26 February 2021
                Categories
                Subject: Article

                Keywords: covid-19,sexual,gender,minority,vaccine,acceptance
                Data availability:
                Keywords: covid-19, sexual, gender, minority, vaccine, acceptance

                Comments

                Comment on this article

                scite_

                Similar content248

                See all similar

                Cited by18

                See all cited by

                Most referenced authors743

                See all reference authors